Publikasi Scopus FKUI 2021 per tanggal 31 Juli 2021 (507 artikel)

Nelwan E.J., Tunjungputri R.N., Tunjung N., Widodo D.
14527452900;56342194400;57208446370;8231822900;
Hospital-acquired Skin and Skin-structure Infection in COVID-19 Infected Patient with Prolonged Hospitalization
2021
Acta medica Indonesiana
53
1
105
107
Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo HospitalJakarta, Indonesia
Nelwan, E.J., Division of Tropical and Infectious Disease, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo HospitalJakarta, Indonesia; Tunjungputri, R.N.; Tunjung, N.; Widodo, D.
Acute bacterial skin and skin-structure infections (ABSSSI) is defined in 2013 by the US Food and Drug Administration as a bacterial cellulitis/erysipelas, major skin abscesses, and wound infections. The Infectious Diseases Society of America (IDSA) in 2014 classifies skin and soft-tissue infection (SSTI) as either non-purulent (which includes cellulitis, erysipelas, and necrotizing infection) or purulent (including furuncle, carbuncle, and abscess). Among hospitalized patients with SSTI, healthcare-associated infections account for 73.5% of all cases. Notably, skin and skin-structure infections caused by Pseudomonas aeruginosa, a common hospital pathogen, was reported to cause higher total cost and longer hospital length of stay compared to non-P. aeruginosa cases, despite causing only approximately 5.7% of all healthcare-associated SSTIs. Infection with P. aeruginosa should always be considered in non-healing skin infections in patients with prolonged hospitalization and antibiotic exposure. Tissue culture, preferably taken by surgical debridement, should be promptly performed; and when hospital-infection is suspected, appropriate antibiotics should be started along with removal of all devitalized tissue and to promote skin and soft tissue healing. Expedited discharge should be considered when possible, with adequate antibiotic treatment and follow up for definitive wound treatment.
COVID-19; Hospital-acquired skin; prolonged hospitalization; skin-structure infection
antiinfective agent; linezolid; case report; complication; debridement; female; hospitalization; human; iatrogenic disease; isolation and purification; microbiology; middle aged; pathology; pathophysiology; procedures; skin; skin infection; treatment outcome; Anti-Bacterial Agents; COVID-19; Debridement; Female; Hospitalization; Humans; Iatrogenic Disease; Linezolid; Middle Aged; SARS-CoV-2; Skin; Skin Diseases, Infectious; Treatment Outcome
NLM (Medline)
1259326
33818413
Article
Q3
321
14162